STRATA Skin Sciences Confirms Nasdaq Delisting
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis
Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences [Yahoo! Finance]
Strata Skin Sciences (NASDAQ:SSKN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.